Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program| (NASDAQ: DTIL) | Delayed: 6.22 -0.11 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.33 | 52 Week High | $ | |||
| Open | $6.35 | 52 Week Low | $ | |||
| Day High | $6.55 | P/E | N/A | |||
| Day Low | $6.18 | EPS | $ | |||
| Volume | 203,993 | |||||

